Cargando…

The emerging role of 5-hydroxymethylcytosine in neurodegenerative diseases

DNA methylation primarily occurs within human cells as a 5-methylcytosine (5mC) modification of the cytosine bases in CpG dinucleotides. 5mC has proven to be an important epigenetic mark that is involved in the control of gene transcription for processes such as development and differentiation. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Mahdawi, Sahar, Virmouni, Sara Anjomani, Pook, Mark A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256999/ https://www.ncbi.nlm.nih.gov/pubmed/25538551 http://dx.doi.org/10.3389/fnins.2014.00397

Ejemplares similares

Epigenetic-based therapies for Friedreich ataxia
por: Sandi, Chiranjeevi, et al.
Publicado: (2014)

HMTase Inhibitors as a Potential Epigenetic-Based Therapeutic Approach for Friedreich’s Ataxia
por: Sherzai, Mursal, et al.
Publicado: (2020)

Cellular, Molecular and Functional Characterisation of YAC Transgenic Mouse Models of Friedreich Ataxia
por: Anjomani Virmouni, Sara, et al.
Publicado: (2014)

MutLα Heterodimers Modify the Molecular Phenotype of Friedreich Ataxia
por: Ezzatizadeh, Vahid, et al.
Publicado: (2014)

Generation and Characterisation of Friedreich Ataxia YG8R Mouse Fibroblast and Neural Stem Cell Models
por: Sandi, Chiranjeevi, et al.
Publicado: (2014)

Identification of telomere dysfunction in Friedreich ataxia
por: Anjomani Virmouni, Sara, et al.
Publicado: (2015)

A novel GAA-repeat-expansion-based mouse model of Friedreich’s ataxia
por: Anjomani Virmouni, Sara, et al.
Publicado: (2015)

Friedreich Ataxia Patient Tissues Exhibit Increased 5-Hydroxymethylcytosine Modification and Decreased CTCF Binding at the FXN Locus
por: Al-Mahdawi, Sahar, et al.
Publicado: (2013)

A new FRDA mouse model [Fxn(null):YG8s(GAA) > 800] with more than 800 GAA repeats
por: Kalef-Ezra, Ester, et al.
Publicado: (2023)

Selective Chemical Labeling and Sequencing of 5-Hydroxymethylcytosine in DNA at Single-Base Resolution
por: Li, Xiaogang, et al.
Publicado: (2021)

Global and Site-Specific Changes in 5-Methylcytosine and 5-Hydroxymethylcytosine after Extended Post-mortem Interval
por: Gross, Jeffrey A., et al.
Publicado: (2016)

i5hmCVec: Identifying 5-Hydroxymethylcytosine Sites of Drosophila RNA Using Sequence Feature Embeddings
por: Liu, Hang-Yu, et al.
Publicado: (2022)

5-Hydroxymethylcytosine-mediated active demethylation is required for mammalian neuronal differentiation and function
por: Stoyanova, Elitsa, et al.
Publicado: (2021)

A Novel Application of Mixed Effects Models for Reconciling Base-Pair Resolution 5-Methylcytosine and 5-Hydroxymethylcytosine Data in Neuroepigenetics
por: Kochmanski, Joseph, et al.
Publicado: (2019)

PARK2 loss promotes cancer progression via redox-mediated inactivation of PTEN
por: Gupta, Amit, et al.
Publicado: (2017)

Epigenomic landscape of 5-hydroxymethylcytosine reveals its transcriptional regulation of lncRNAs in colorectal cancer
por: Hu, Hanyang, et al.
Publicado: (2017)

Epigenetics in Friedreich's Ataxia: Challenges and Opportunities for Therapy
por: Sandi, Chiranjeevi, et al.
Publicado: (2013)

HMG-boxes, ribosomopathies and neurodegenerative disease
por: Moss, Tom, et al.
Publicado: (2023)

The effect of chemotherapeutic agents on telomere length maintenance in breast cancer cell lines
por: Motevalli, Azadeh, et al.
Publicado: (2014)

Analysis of alternative lengthening of telomere markers in BRCA1 defective cells
por: Kargaran, Parisa K., et al.
Publicado: (2016)

Physiological and pathological implications of 5-hydroxymethylcytosine in diseases
por: Liang, Jing, et al.
Publicado: (2016)

5-hydroxymethylcytosine and its potential roles in development and cancer
por: Pfeifer, Gerd P, et al.
Publicado: (2013)

The potential of epigenetic therapies in neurodegenerative diseases
por: Coppedè, Fabio
Publicado: (2014)

Alterations of 5-Hydroxymethylcytosine in Human Cancers
por: Mariani, Christopher J., et al.
Publicado: (2013)

The Behaviour of 5-Hydroxymethylcytosine in Bisulfite Sequencing
por: Huang, Yun, et al.
Publicado: (2010)

Formation and Abundance of 5-Hydroxymethylcytosine in RNA
por: Huber, Sabrina M, et al.
Publicado: (2015)

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
por: Sjöström, Martin, et al.
Publicado: (2022)

5-Hydroxymethylcytosine Loss in Conjunctival Melanoma
por: Stahl, Alexandre, et al.
Publicado: (2021)

Network approaches for omics studies of neurodegenerative diseases
por: Zhao, Na, et al.
Publicado: (2022)

FAST-1 antisense RNA epigenetically alters FXN expression
por: Mikaeili, Hajar, et al.
Publicado: (2018)

Cell-free DNA 5-hydroxymethylcytosine is an emerging marker of acute myeloid leukemia
por: Shao, Jianming, et al.
Publicado: (2022)

Structural disorder and the loss of RNA homeostasis in aging and neurodegenerative disease
por: Gray, Douglas A., et al.
Publicado: (2013)

Variation in 5-hydroxymethylcytosine across human cortex and cerebellum
por: Lunnon, Katie, et al.
Publicado: (2016)

Ontogeny, distribution and potential roles of 5-hydroxymethylcytosine in human liver function
por: Ivanov, Maxim, et al.
Publicado: (2013)

Role of ten‐eleven translocation proteins and 5‐hydroxymethylcytosine in hepatocellular carcinoma
por: Wang, Penghui, et al.
Publicado: (2019)

Tet-Mediated Formation of 5-Hydroxymethylcytosine in RNA
por: Fu, Lijuan, et al.
Publicado: (2014)

Genomic mapping of 5-hydroxymethylcytosine in the human brain
por: Jin, Seung-Gi, et al.
Publicado: (2011)

Distribution of 5-Hydroxymethylcytosine in Different Human Tissues
por: Li, Weiwei, et al.
Publicado: (2011)

Environmental Epigenetics and Genome Flexibility: Focus on 5-Hydroxymethylcytosine
por: Efimova, Olga A., et al.
Publicado: (2020)

Non-coding RNA and pseudogenes in neurodegenerative diseases: “The (un)Usual Suspects”
por: Costa, Valerio, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7vu5cbgeekent35galu0actsdn